Cytogenetic and Genome Research
Relationship between DNA Repair and Formation of Sister Chromatid Exchanges and Chromatid Aberrations under the Influence of Poly(ADP-Ribose) Polymerase Inhibition by 3-AminobenzamideFilippi S.a · Palitti F.a · Martínez-López W.a, c · Fiore M.b · Natarajan A.T.aaDepartment of Agrobiology and Agrochemistry, University of Tuscia, Viterbo, and bInstitute of Molecular Biology and Pathology, CNR, Department of Genetics and Molecular Biology, University La Sapienza, Rome, Italy; cEpigenetics and Genomic Instability Laboratory, Instituto de Investigaciones Biológicas Clemente Estable, Montevideo, Uruguay
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Published online: April 09, 2010
Issue release date: May 2010
Number of Print Pages: 6
Number of Figures: 1
Number of Tables: 3
ISSN: 1424-8581 (Print)
eISSN: 1424-859X (Online)
For additional information: https://www.karger.com/CGR
Abstract
The mechanisms of formation of sister chromatid exchanges (SCEs) and chromosome aberrations following inhibition of poly(ADP-ribose) polymerase by 3-aminobenzamide were studied in Chinese hamster ovary cell lines deficient in different repair pathways. The results confirm earlier findings that (a) the ‘spontaneous’ SCEs are formed due to the incorporated BrdU in the DNA, (b) ‘spontaneous’ and induced SCEs originate from different mechanisms, and (c) SCEs and chromatid exchanges are formed by different pathways.
© 2010 S. Karger AG, Basel
Related Articles:
References
- Benjamin RC, Gill DM: Poly (ADP-ribose) synthesis in vitro programmed by damaged DNA. A comparison of DNA molecules containing different types of strand breaks. J Biol Chem 255:10502–10508 (1980).
- Blunt T, Finnie NJ, Taccioli GE, Smith GCM, Demengeot J, et al: Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation p813. Cell 80:813–823 (1995).
- Chaganti RS, Schonberg S, German J: A manyfold increase in sister chromatid exchanges in Bloom’s syndrome lymphocytes. Proc Natl Acad Sci USA 71:4508–4512 (1974).
- Fisher AE, Hochegger H, Takeda S, Caldecott KW: Poly(ADP-ribose) polymerase 1 accelerates single-strand break repair in concert with poly(ADP-ribose) glycohydrolase. Mol Cell Biol 27:5597–5605 (2007).
- Hassa PO, Haenni SS, Elser M, Hottiger MO: Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going? Microbiol Mol Biol Rev 70:789–829 (2006).
- Hinz JM, Tebbs RS, Wilson PF, Nham PB, Salazar EP, et al: Repression of mutagenesis by Rad51D-mediated homologous recombination. Nucleic Acids Res 34:1358–1368 (2006).
- Jones NJ, Stewart SA, Thompson LH: Biochemical and genetic analysis of the Chinese hamster mutants irs1 and irs2 and their comparison to cultured ataxia telangiectasia cells. Mutagenesis 5:15–23 (1990).
- Kato H: Possible role of DNA synthesis in formation of sister chromatid exchanges. Nature 252:739–741 (1974).
- Latt S: Microfluorimetric detection of deoxyribonucleic acid replication in human metaphase chromosomes. Proc Natl Acad Sci USA 70:3395–3399 (1973).
- Lorenti Garcia C, Mechilli M, Proietti De Santis L, Schinoppi A, Kobos K, Palitti F: Relationship between DNA lesions, DNA repair and chromosomal damage induced by acetaldehyde. Mutat Res 662:3–9 (2009).
- Meschini R, Marotta E, Berni A, Filippi S, Fiore M, et al: DNA repair deficiency and BPDE-induced chromosomal alterations in CHO cells. Mutat Res 637:93–100 (2008).
- Natarajan AT, Csukas I, van Zeeland AA: Contribution of incorporated 5-bromodeoxyuridine in DNA to the frequencies of sister chromatid exchanges induced by inhibitors of poly(ADP-ribose) polymerase. Mutat Res 84:125–132 (1981).
-
Natarajan AT, van Zeeland AA, Zwanenburg TSB: Influence of inhibitors of poly(ADP-ribose) polymerase on DNA repair, chromosomal alterations and mutations, in Miwa M, Hayashi O, Shall S, Smulson M, Sugimura T (eds): ADP-Ribosylation and Cancer, pp 227–242 (Japan Sci Soc Press, Tokyo/VNU Science Press, Utrecht 1983a).
- Natarajan AT, Tates AD, Meijers M, Neuteboom I, Vogel N: Induction of sister chromatid exchanges (SCEs) and chromosomal aberrations by mitomycin C and methyl methanesulphonate in Chinese hamster ovary cells. An evaluation of methodology for detection of SCEs, persistent DNA lesions towards the frequencies of observed SCEs. Mutat Res 121:211–223 (1983b).
- Natarajan AT, Rotteveel AH, van Pieterson J, Schilermann MG: Influence of incorporated 5-bromodeoxyuridine on the frequencies of spontaneous and induced sister-chromatid exchanges, detected by immunological methods. Mutat Res 163:51–55 (1986).
- Natarajan AT, Berni A, Marimuthu KM, Palitti F: The type and yield of ionising radiation induced chromosomal aberrations depend on the efficiency of different DSB repair pathways in mammalian cells. Mutat Res 642:80–85 (2008).
- Palitti F, Becchetti A: Effect of caffeine on sister chromatid exchanges and chromosomal aberrations induced by mutagens in Chinese hamster cells. Mutat Res 45:157–159 (1977).
- Perry P, Wolff S: New Giemsa method for the differential staining of sister chromatids. Nature 251:156–158 (1974).
- Pinkel D, Thompson LH, Gray JW, Vanderlaan M: Measurement of sister chromatid exchanges at very low bromodeoxyuridine substitution levels using a monoclonal antibody in Chinese hamster ovary cells. Cancer Res 45:5795–5798 (1985).
- Ralf C, Hickson ID, Wu L: The Bloom’s syndrome helicase can promote the regression of a model replication fork. J Biol Chem 281:22839–22846 (2006).
- Sutou S: Spontaneous sister-chromatid exchanges in Chinese hamster cells in vivo and in vitro. Mutat Res 82:331–341 (1981).
- Taylor JH: Sister chromatid exchanges in tritium-labeled chromosomes. Genetics 43:515–526 (1958).
- Tebbs R, Hinz JM, Yamada NA, Wilson JB, Salazar EP, et al: New insights into the Fanconi anemia pathway from an isogenic FancG hamster CHO mutant. DNA Repair 4:11–22 (2005).
- Thompson LH, Brookman KW, Dillehey LE, Carrano AV, Mazrimas JA, Mooney CI, Minkler JL: A CHO cell strain having hypersensitivity to mutagens, a defect in DNA strand break repair, and an extraordinary baseline frequency of sister chromatid exchange. Mutat Res 95:427–440 (1982).
- Troelstra C, Odijk H, de Wit J, Westerveld A, Thompson LH, Bootsma D, Hoeijmakers JHJ: Molecular cloning of the human DNA repair gene ERCC6. Mol Cell Biol 10:5806–5813 (1990).
-
Uggla AH, Natarajan AT: SCE in Plants, in Sandberg AA (ed): Sister Chromatic Exchange, pp 217–233 (Alan R. Liss Inc., New York 1982).
- Westerveld A, Hoeijmakers JHJ, van Duin M, de Wit J, Odijk H, et al: Molecular cloning of a human DNA repair gene. Nature 310:425–429 (1984).
- Zwanenburg TS, Natarajan AT: 3-Aminobenzamide-induced sister chromatid exchanges are dependent on incorporated bromodeoxyuridine in DNA. Cytogenet Cell Genet 38:278–281 (1984).
Article / Publication Details
Published online: April 09, 2010
Issue release date: May 2010
Number of Print Pages: 6
Number of Figures: 1
Number of Tables: 3
ISSN: 1424-8581 (Print)
eISSN: 1424-859X (Online)
For additional information: https://www.karger.com/CGR
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
